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Case Report
Dental and Craniofacial Characteristics in a Patient with Leprechaunism
Treated with Insulin-Like Growth Factor-I
Tomohiro Fukunagaa; Takashi Murakamib; Hiroyuki Tanakac; Shouichi Miyawakid;
Takashi Yamashiroe; Teruko Takano-Yamamotof
ABSTRACT
Leprechaunism is an autosomal recessive disease characterized by elfin-like faces, loss of glu-
cose homeostasis, and severe insulin resistance. This disease is caused by inherited defects of
the insulin receptor and is lethal early in life. Perhaps for this reason, the teeth and craniofacial
features of patients with leprechaunism have never been reported. In the present case, the patient
had been diagnosed with leprechaunism with mutation in the insulin receptor gene and had treat-
ment with recombinant human insulin-like growth factor I (IGF-I) starting at the age of 1 year 7
months. It is of interest that all of his teeth were extremely large and subsequently showed severe
crowding in the dental arches. He also showed a large tongue with an anterior open bite. He had
a convex facial profile with a remarkably steep mandibular plane angle and large gonial angle.
This is the first report of the characteristic phenotypes of the teeth and craniofacial morphology
of a patient with leprechaunism treated with IGF-I. In addition, the possible association between
these features and long-term IGF-I treatment is discussed.
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INTRODUCTION
Leprechaunism is a rare congenital syndrome as-
sociated with extreme insulin resistance.1 In addition
to insulin resistance, leprechaunism features are char-
acterized by a peculiar elfin-like face (low-set and
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large ears, depressed nasal bridge with a broad nasal
tips, anteverted nares, and thick lips), decreased sub-
cutaneous fat, acanthosis nigricans, retarded intra-
uterine and postnatal growth, and hirsutism.1,2
The insulin resistance in leprechaunism has been
shown to be caused by mutations in the insulin recep-
tor gene.3,4 Insulin exerts both metabolic and mitogenic
effects on its target cells through the insulin receptor.5
Defects of insulin action result in retarded intrauterine
growth and metabolic dysfunction in humans.4–6 In ad-
dition, infants with leprechaunism characteristically
show hirsutism.2 Like hair, teeth are ectodermal ap-
pendage organs; however, the tooth phenotype in pa-
tients with leprechaunism is not known because these
patients usually do not survive infancy.
Insulin-like growth factor I (IGF-I), a polypeptide with
extensive structural homology to insulin (48%), has
major insulin-like effects on glucose uptake, glycolysis,
and glycogen synthesis in vitro and in vivo.7,8 Previ-
ously, it has been reported that short-term treatment
with recombinant human IGF-I (rhIGF-I) improved glu-
cose metabolism in patients with the genetic form of
insulin resistance.3,9 A recent report also showed that
long-term treatment with rhIGF-I works effectively to
prevent postnatal growth retardation and normalize
glucose metabolism in patients with leprechaunism.10
In addition, Di Cola et al8 reported that IGF-I could
mimic insulin’s effects on glucose metabolism by act-
ing through its own receptor in mice genetically defi-
746 FUKUNAGA, MURAKAMI, TANAKA, MIYAWAKI, YAMASHIRO, TAKANO-YAMAMOTO
Angle Orthodontist, Vol 78, No 4, 2008
Figure 1. Photograph of a patient with leprechaunism, aged 11
years 11 months.
Figure 2. Hand-wrist radiograph indicates that the bone age was
11.5 years. This was almost coincident with the chronological age.
cient for insulin receptors. However, because IGF-I
promotes growth and differentiation in a variety of tis-
sues,11 possible side effects of IGF-I treatment regard-
ing tooth and craniofacial anatomy should be noted.
In the present case study, we found that a patient
with leprechaunism showed significantly large-sized
teeth and severely crowded malocclusion. He had had
long-term treatment with recombinant IGF-I. We dis-
cuss below whether the enlargement of tooth size was
due to a tooth phenotype caused by the defect of the
insulin receptor or due to the side effects of long-term
IGF-I treatment. In addition, the patient showed a spe-
cific abnormal craniofacial growth pattern, and we also
discuss the possible association between it and long-
term IGF-I treatment.
CASE REPORT
A patient with leprechaunism, an 11-year 11-month-
old boy, presented at the orthodontic clinic of Okaya-
ma University Dental Hospital with complaints of
crowded teeth and anterior open bite. His height and
weight were 133.3 cm (2.3 SD) and 29.9 kg, re-
spectively (Figure 1). The bone age was 11.5 years,
as estimated by hand-wrist radiograph12 (Figure 2). He
showed typical features of leprechaunism, including
large and low-set ears, depressed nasal bridge with a
broad nasal tip, hirsutism, and acanthosis nigricans in
the axilla and around the neck (Figure 3). The tongue
was large and, when extended, was long enough to
reach the mentum (Figure 4). An anterior open bite
with an overjet of 3 mm and overbite of 7 mm was
observed (Figure 5). Because of enlarged teeth, se-
vere crowding of 23 mm in the maxillary arch and of
19 mm in the mandibular arch was present (Figure 5).
Moreover, the upper and lower canines and lower pre-
molars were malformed teeth (Figure 5; Table 1).
The panoramic radiograph revealed that all second
molar roots were developed and all third molar roots
were developing (Figure 6). Cast analysis showed that
the size of all teeth was remarkably larger than the Jap-
anese norm13 (Table 1). Cephalometrically, when com-
pared with the normative values for Japanese males of
corresponding age,14 the patient had a skeletal Class I
jaw base relationship (ANB 1.9; Figure 7; Table 2). The
mandibular length was increased (Ar-Me 111.2 mm), but
the mandibular body length and ramus height were with-
in the reference range (Go-Me 72.4 mm, Ar-Go 42.1
mm). The mandibular plane angle was remarkably steep
with a significantly large gonial angle (mand. pl.-FH
48.5, Go.A 153.1; Figure 7; Table 2). These data in-
dicate that the mandible was protruded but simulta-
neously rotated in the inferior direction. Both the upper
and lower incisors were severely labially inclined (U1/FH
125.7, L1/FH 45.8, L1/MP 85.7; Figure 7; Table 2).
These skeletal and dental characteristics were also
confirmed in a 3-dimensional computed tomography
image, as shown in Figure 8. The condyle was normal
in morphology, and the articular disc was positioned
properly, as observed in the tomographs and magnetic
resonance image, respectively (Figure 9). However, a
6-degree-of-freedom jaw recording system revealed
that the condyle moved asymmetrically and that left
condylar movement was limited in range during open-
and-close jaw movement (Figure 9). The maximum oc-
clusal force and occlusal contact area during maxi-
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Figure 3. (A) Facial profile shows the low-set ears. (B, C) Close-up of the large ears. (D) Close-up of the depressed nasal bridge with broad
nasal tip. (E) Hirsutism of the arm. (F) Acanthosis nigricans around the neck.
Figure 4. Photographs of protruded tongue. Note extremely large
volume of tongue.
Figure 5. Intraoral photographs show that severe crowding in both arches with large size of all the teeth.
mum clenching showed small values in comparison
with the Japanese norm15 (Table 3).
The patient’s medical record showed that he was born
after 40 weeks of gestation as a normal-for-gestational-
age infant with a birth weight and length of 2736 g and
47 cm, respectively. He was diagnosed with leprechaun-
ism at Saitama Children’s Medical Center because he
showed an extreme degree of insulin resistance (blood
glucose, 121 mg/dL; corresponding serum immunore-
active insulin, 3575 U/mL), hirsutism, large penis, ac-
anthosis nigricans, and delayed mental development.16
Molecular analysis revealed a missense mutation
causing substitution of Met for Thr at position 910 of
the insulin receptor gene, and this mutation affected
insulin binding by impairing receptor processing.16 At
the age of 1 year 7 months, he started to receive ad-
ministration of subcutaneous injection of recombinant
human IGF-I (Fujisawa Pharmaceutical Co, Osaka,
Japan) twice a day at a dose of 0.1 mg/kg body
weight. Thereafter, IGF-I (0.05–0.2 mg/kg body
weight) was given daily in the morning and in the
evening. At the age of 6 years 8 months, he underwent
tonsillectomy. In addition, nephrocalcinosis and cho-
lesteatoma were found by ultrasonic observation.
DISCUSSION
In this patient with leprechaunism treated with
rhIGF-I, we observed remarkable enlargement of all
his dentition, and all the teeth showed early maturity.
Patients with leprechaunism commonly die early in
life.1–4 In the present case, the patient has been treat-
ed with rhIGf-I from the age of 1 year 7 months. There-
fore, the tooth phenotype of leprechaunism cannot be
evaluated in this patient independent of the influence
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Figure 6. Panoramic radiograph revealed that all second molar roots
were developed and all third molar roots were developing. This in-
dicates that dental age is advanced compared with chronological
age.
Table 2. Cephalometric Summarya
Measurement
Value
(11 y 11 mo) Z-scoreb
Mean (Japanese
Male, Aged 12 y) SD
Angular, 
SNA 77.3 1.3 81.6 3.4
SNB 75.4 0.5 77.2 3.7
ANB 1.9 1.1 4.3 2.2
Mp-FH 48.5 3.5 30.6 5.1
Gonial angle 153.1 4.7 125 5.9
U1-FH 125.7 2.0 111.3 7.1
L1-FH 45.8 1.1 53.6 6.8
L1-Mp 85.7 1.9 95.7 5.4
Linear, mm
S-N 72.7 1.5 68.5 2.8
Ans-Ptm 56.3 1.1 53.2 2.7
Ar-Go 42.1 0.8 44.9 3.7
Go-Me 72.4 0.8 69.1 4.4
Ar-Me 111.2 1.3 103.4 5.9
Overjet 2.7 0.6 3.4 1.2
Overbite 7.1 7.1 3.5 1.5
a Means and standard deviations are from the work of Wada et
al.14
b The Z-score was calculated as (value – mean)/1 SD.
of long-term treatment with rhIGF-I. Thus, it is not clear
whether the enlargement of the teeth was due to the
impaired function of the insulin receptor or due to un-
favorable side effects of the long-term IGF-I treatment.
‘‘In vitro and in vivo’’ IGF-I stimulates cell growth in a
variety of tissues.11 In tooth development, IGF-I in the
continuously erupting rat incisor is expressed in odon-
toblasts and ameloblasts, and its receptor is also ex-
pressed in these cells.17–19 Interestingly, IGF-I in-
creased the mouse tooth germ volume by about two-
fold compared with 20% fetal calf serum treatment
when the tooth germ was cultured in dishes for 6
days.20 In addition, IGF-I stimulates the root elongation
of mouse mandibular molars in vitro.21
On the other hand, Laron-type dwarfism is charac-
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Figure 7. (A) Cephalometric radiograph. (B) Cephalometric tracing. Tracing was superimposed on the mean profilogram. Note that the man-
dibular length was increased and the mandibular plane angle was remarkably steep with a significantly large gonial angle.
Figure 8. Three-dimensional computed tomography images.
terized by growth hormone resistance, which leads to
an inability to synthesize IGF-I.22 In patients with La-
ron-type dwarfism who do not receive treatment, a
high prevalence of missing third molars (in more than
90% of the patients) and hypodontia (in more than
30% of the patients) compared with the normal pop-
ulation was reported.23 Moreover, permanent teeth in
these patients tended to have smaller mesiodistal di-
ameters.23 In addition, although such patients have the
clinical feature of prolonged retention of the primary
dentition, IGF-I treatment for 1 year induces the loss
of deciduous teeth and appearance of permanent den-
tition.24
Taken together, these findings suggest that IGF-I has
strong anabolic effects on tooth development and could
affect the size of the teeth and tooth development. How-
ever, patients with Rabson-Mendenhall syndrome, which
is characterized by extreme insulin resistance caused by
mutations in the insulin receptor gene, have early erup-
tion of permanent teeth, dental abnormalities, and irreg-
ularly placed and crowded teeth.4 Therefore, it is likely
that the enlarged teeth in our patient with leprechaunism
were due to some side effect of long-term treatment of
IGF-I as well as the tooth phenotype induced by insulin
receptor impairment.
The patient showed a skeletal open bite tendency
with protruded mandible and increased gonial angle.
Anterior open bite is often observed associated with
macroglossia and mouth breathing. Our patient actu-
ally showed macroglossia. This might have led to pro-
trusion and clockwise rotation of the mandible, pre-
sumably to seek wide space in an insufficiently oral
cavity. Recently, it has been reported that 4-week ad-
ministration of IGF-I induced the increases of tongue
weight as well as muscle-bundle width and epithelial
thickness of the tongue in the 10-week-old rat.25 In ad-
dition, the IGF-I receptor was expressed in most of the
taste bud cells of adult mice by immunohistochemistry
and those of postnatal day 6 mice by in situ hybridiza-
tion.26 Hence, it is speculated that the tongue might
respond to IGF-I more than other craniofacial organs,
and the macroglossia observed in patients with lep-
rechaunism might be due to the unfavorable effects of
long-term treatment with rhIGF-I. Furthermore, rhIGF-
I–induced macroglossia might lead to a characteristic
craniofacial growth pattern as a secondary effect.
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Figure 9. (A) Tomographs. (B) Magnetic resonance imaging. Arrows show disc position. Rt indicates right side; Lt, left side; (C), condylar
movement and incisal paths during maximum open-and-close jaw movement as detected using a 6-degrees-of-freedom jaw movement re-
cording system.
Table 3. Maximum Occlusal Force and Occlusal Contact Areaa
Measurement
Value
(11 y
11 mo) Z-scoreb
Mean (Japanese
Prepubertal
Subjects) SD
Occlusal force (N) 86.0 1.5 448.7 240.4
Contact area 1.94 1.1 11.9 9.0
a Means and standard deviations are from the work of Miyawaki
et al.15
b The Z-score was calculated as (value – mean)/1 SD.
However, this patient needs continuous treatment with
IGF-I to survive. In the future treatment of this patient,
we have to take special note of the tongue growth and
the mandibular growth, taking account of the clockwise
rotation. If the skeletal open bite tendency should
worsen, glossectomy might be indicated in the future.
It has been reported that most Laron-type dwarfism
patients treated with rhIGF-I have an apparent increase
in the size of their nasopharyngeal lymphoid tissue.27 Ac-
tually, our patient had a history of hypertrophy of tonsil
and underwent tonsillectomy at age 6. Hypertrophy of
the tonsils has also been reported in leprechaunism and
Laron-type dwarfism patients who have been treated
with rhIGF-I.10,27 Therefore, the hypertrophy of the tonsils
in this patient might have been due to IGF-I treatment.
Hypertrophy of the tonsils is the major cause of re-
spiratory obstructions in childhood, and airway ob-
struction might lead to mouth breathing. The parents
of this patient reported that his snoring during sleeping
was improved by tonsillectomy, suggesting that hy-
pertrophy of the tonsils might actually have caused air-
way obstruction in this patient. Respiratory problems
possibly cause postural alterations of the mandible
and consequently induce clockwise rotation of the
mandible with lip incompetence.28
This patient showed very a small maximum occlusal
force. In an animal study, insulin receptor substrate–1
deficiency resulted in decreases in various organs
weights, such as kidney, brain, intestine, spleen, heart,
liver, and gastrocnemius muscle, and transgenically
overexpressed IGF-I rescued such weight reduction,
except in the gastrocnemius muscle.29 Therefore, a
weak occlusal force in this patient might be due to
muscle problems that were induced by the insulin re-
ceptor mutation in leprechaunism with insufficient res-
cue by IGF-I. In addition, the present case showed a
large gonial angle and steep mandibular plane angle,
and it is well known that long-face adults show weak
occlusal force.15,30 Hence, it is also possible that the
weak occlusal force was due to the craniofacial char-
acteristic of a long face.
Our observations suggest that long-term IGF-I treat-
ment could cause unfavorable side effects on tooth size
and the craniofacial growth pattern. However, without
continuous treatment with rhIGF-I, leprechaunism is a
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lethal disease. Several groups have reported that this
therapy had the benefits of normalizing glucose metab-
olism and preventing postnatal growth retardation in pa-
tients with extreme insulin resistance.3,9,10 The dentition
and craniofacial growth of these patients should be care-
fully monitored by orthodontists to minimize unfavorable
side effects as much as possible. Glossectomy and/or
tonsilectomy might be indicated if the tongue or the ton-
sils become large. Tooth extraction treatment might also
be indicated if the patients show severely crowded teeth
due to their enlarged size.
Previously, these patients could not survive for more
than 1 or 2 years. However, recent biotechnology en-
ables treatment of this lethal condition, and conse-
quently, we encountered in this patient a dental and
craniofacial phenotype that has not previously been
reported. As in this disease, new therapies are con-
stantly being developed for severe and/or fetal diseas-
es. It is therefore likely that orthodontists will have
more opportunities in the future to find new types of
malocclusion that have not yet been observed.
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